8VC GP I, LLC
Follow13F filer, CIK 1667766, AUSTIN, TX
8VC GP I, LLC reported $73,091,129 across 3 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-07.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-24-010539
- Period
- 2024-09-30
- Reported value
- $73.1M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| Senti Biosciences, Inc.reduced | -2,283,803 | -$5.16M |
| BIOMX INCreduced | -977,570 | -$997K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2024
Share positions as resolved from 13F-HR 0000950123-24-010539, largest first. % of portfolio is the value over $73,091,129, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| JOBYJOBY AVIATION INC | 14,395,000 | $72.4M | 99.06% | 0 | Timeline | ||
| Senti Biosciences, Inc.Senti Biosciences, Inc. | 253,755 | $573K | 0.78% | -2,283,803 | |||
| BIOMX INCBIOMX INC | 108,621 | $111K | 0.15% | -977,570 |
How Q3 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-24-010539 | base | 2024-11-07 | acceptance time not in the bulk data set |